Melanoma clinical trials
620 studies are looking for volunteers right now. Search near you to see which are close by and who can take part.
Or see all melanoma studies in TrialFinder. Live data from ClinicalTrials.gov, updated daily.
At a glance
Where the studies are
U.S. states with the most recruiting melanoma studies. A study counts once in each state where it has a site.
- Texas122
- California120
- New York103
- Florida95
- Pennsylvania92
- Ohio86
- Michigan70
- Tennessee70
- Massachusetts68
- Virginia68
- Colorado65
- North Carolina62
Also in China (93), France (70), Australia (63), Italy (53), Spain (50), Germany (46), Canada (45), United Kingdom (40).
Types of study
Phases 1 to 4 test medicines, from first safety checks to long-term follow-up after approval. Trials of devices and programs have no phase. Observational studies give no study treatment.
- Early phase 112
- Phase 197
- Phase 1 / Phase 294
- Phase 2116
- Phase 2 / Phase 311
- Phase 346
- Phase 45
- No phase (devices, programs)101
- Observational138
Recently updated studies
Recruiting melanoma studies whose listing changed most recently. Open one in TrialFinder to check if you might qualify.
- RecruitingPhase 3NCT04267848
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Ages 18 Years and over · Anchorage, Alaska · Fairbanks, Alaska +749 more · National Cancer Institute (NCI)
- RecruitingPhase 3NCT07221734
Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 Versus EU-/US-Opdivo® in Subjects With Previously Untreated Advanced [Unresectable or Metastatic] Melanoma
Ages 18 Years and over · Banja Luka, Bosnia and Herzegovina · Sarajevo, Bosnia and Herzegovina +53 more · mAbxience Research S.L.
- RecruitingPhase 3NCT04181060
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Ages 18 Years and over · Anchorage, Alaska · Fairbanks, Alaska +426 more · National Cancer Institute (NCI)
- RecruitingPhase 3NCT03486873
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Ages 18 Years and over · Tucson, Arizona · Bakersfield, California +544 more · Merck Sharp & Dohme LLC
- RecruitingPhase 2NCT07406724
HS-IT101 Injection Versus Chemotherapy in the Treatment of Advanced Melanoma(FASTIL-Mela02)
Ages 18 Years – 75 Years · Beijing, China · Hangzhou Huasai Biomedicine Co., Ltd.
- RecruitingPhase 2NCT07574047
MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma.
Ages 18 Years and over · Fribourg, Canton of Fribourg · Basel, Switzerland +7 more · Swiss Cancer Institute
- RecruitingPhase 1 / Phase 2NCT07751042
Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
Ages 18 Years and over · Scottsdale, Arizona · Boston, Massachusetts +2 more · Strand Therapeutics Inc.
- RecruitingObservationalNCT04609072
Connect for Cancer Prevention Study (Connect)
Ages 30 Years – 70 Years · Denver, Colorado · Atlanta, Georgia +8 more · National Cancer Institute (NCI)
Worth knowing
- Taking part is your choice, and you can stop at any time.
- Each study has rules about who can join. The study team checks them with you before you start.
- Talk to your doctor about whether a study is a good fit for you.